Roche Partners With Peptide Specialist Aileron For Five Targets
A $25 million upfront commitment could blossom into a deal worth as much as $1.1 billion plus royalties.
A $25 million upfront commitment could blossom into a deal worth as much as $1.1 billion plus royalties.